Garland C F, Garland F C, Gorham E D
Department of Community and Family Medicine, University of California, San Diego, La Jolla 92093-0607.
Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S-201S. doi: 10.1093/ajcn/54.1.193S.
It was proposed in 1980 that vitamin D and calcium could reduce the risk of colon cancer. This assertion was based on the decreasing gradient of mortality rates from north to south, suggesting a mechanism related to a favorable influence of ultraviolet-induced vitamin D metabolites on metabolism of calcium. A 19-y prospective study of 1954 Chicago men found that a dietary intake of greater than 3.75 micrograms vitamin D/d was associated with a 50% reduction in the incidence of colorectal cancer, whereas an intake of greater than or equal to 1200 mg Ca/d was associated with a 75% reduction. Clinical and laboratory studies further support these findings. A nested case-control study based on serum drawn from a cohort of 25,620 individuals reported that moderately elevated concentrations of 25-hydroxyvitamin D, in the range 65-100 nmol/L, were associated with large reductions (P less than 0.05) in the incidence of colorectal cancer.
1980年有人提出,维生素D和钙可以降低患结肠癌的风险。这一论断是基于从北到南死亡率呈下降趋势,这表明存在一种与紫外线诱导的维生素D代谢产物对钙代谢的有利影响相关的机制。一项对1954名芝加哥男性进行的为期19年的前瞻性研究发现,每日膳食中维生素D摄入量超过3.75微克与结直肠癌发病率降低50%相关,而每日钙摄入量大于或等于1200毫克则与发病率降低75%相关。临床和实验室研究进一步支持了这些发现。一项基于从25620人的队列中抽取的血清进行的巢式病例对照研究报告称,25-羟基维生素D浓度适度升高,范围在65-100纳摩尔/升,与结直肠癌发病率大幅降低(P<0.05)相关。